ICI Boston Summit
Returning for the 4th time, ICI Boston is the definitive forum focused exclusively on how to deliver maximum clinical benefit through immune checkpoint modulation.
Rather than attempting to cover the entire IO space and only providing superficial insights, this conference has the focus required to drill down into the real details. Discover how to overcome key preclinical, translational and clinical drug development challenges encountered in the development of checkpoint modulators.
ICI Boston will unite industry leaders including Merck, BMS, Genentech and Novartis to share in-depth case studies on topics such as overcoming resistance to checkpoint blockade, identifying translational biomarkers and understanding the mechanistic rationale behind combination strategies.
Join leading drug developers who have successfully developed IO therapeutics and ensure you make the right decisions with your IO pipeline.
Find out more about the event, agenda topics and speaker line-up here: http://bit.ly/2ifJ8Fv